The results showed that COMMD2/3/10 expression was significantly lower in the high-score group, which indicates that COMMD2/3/10 might be involved in immune infiltration in HCC (p < 0.05) (Fig. 7BCJ). The gene discussed is COMMD2; the disease is hepatocellular carcinoma.